About Transcend Mind
Transcend-Mind by Transcendent Life Sciences, Inc.
By: Hyder A. Khoja, MSc., PAg., PhD.
Founder & CEO-Transcendent Life Sciences, Inc.
Fostering Remedial, Salubrious, and Sanative Health & Well-Being
Our Mission
At Transcendent Life Sciences, we are dedicated to pioneering the science, discovery, and development of therapeutic solutions to transform lives. Our focus is on harnessing the potential of psychedelic and psychoactive compounds to aid patients in vegetative states or comas, resulting from conditions such as Traumatic Brain Injury, severe stroke, increased blood pressure, bleeding, oxygen loss, or toxin buildup.
Our Research
We are at the forefront of Research, Development, and Commercialization, pursuing salubrious and sanative therapeutics to enhance treatments for traumatic brain unconsciousness. Our work targets the Reticular Activating System (RAS), which governs human consciousness. We aim to develop a (Patent-Pending) nutraceutical for Coma Resurrection Therapy (CRT) to help patients emerge from life-threatening conditions.
About Transcend Mind
Our Vision
Transcendent Life Sciences is exploring the therapeutic benefits of nano-molecule formulations, including compounds like Psilocybin and Psilocin, derived from medicinal fungi, mushrooms, plants, herbs, and other organisms. Through controlled, quantifiable laboratory settings, we are testing micro-dosed Active Pharmaceutical Ingredients (API) and Active Nutraceutical Ingredients (ANI). Our research investigates neuron signaling to brain receptors to better understand brain death, consciousness, sub-consciousness, awareness, and deep sleep.
Our Goal
We strive to revolutionize treatment for patients in vegetative states or comas, offering hope through innovative, science-driven solutions. By combining cutting-edge research with a commitment to health and well-being, we aim to lead the way in coma resurrection and consciousness restoration.
About Dr. Hyder A Khoja
Professional Journey
Dr. Khoja is a distinguished leader in high technology and biomedical sciences, renowned for his innovative contributions and business acumen. With a career spanning regulatory programs, science, and policy, he has led multidisciplinary teams of engineers, scientists, and planners, fostering cross-functional expertise in research and business development. His advisory roles for private and publicly traded startups have driven transformative advancements in pharmacology, agriculture, and renewable energy.
Entrepreneurial Ventures
In 2010, Dr. Khoja founded LeoFric Consultants, Inc., delivering knowledge-based solutions to global clients. In 2014, he co-founded InMed Pharmaceuticals, leading botanical drug research that raised over $52 million in market capital. As Vice President for Innovation and Scientific Affairs at Affinor Growers, Inc. in 2015, he advanced vertical farming techniques, collaborating with the US Department of Agriculture to enhance per-acreage yields. Today, he serves as Chief Scientific Officer and board advisor for multiple companies, developing novel therapies from marine and plant-based compounds.
Academic Contributions
Dr. Khoja earned his PhD in Molecular Biology and Genetic Engineering with honors from INP-ENSAT, a French Ivy League institution, followed by postdoctoral training at Michigan State University. He has served as research faculty at Virginia-Tech, University of Wyoming, and Texas-Tech University Health Science Center. Currently, as a Visiting Faculty at Aga Khan University, he supports the Department of Biomedical and Biological Sciences in developing pharmacological applications from natural compounds.
Scientific Impact
Dr. Khoja’s breakthrough research on "Algae 4 Fuel" secured over $25 million from the US Department of Energy and was honored by the United Nations FAO in 2011. His work, published in over 32 peer-reviewed journals, reflects his commitment to advancing science. An elocutionist fluent in 12 international languages, he bridges scientific innovation with global communication.
Vision and Legacy
Dr. Khoja’s career embodies a pursuit of sublimity through creativity, innovation, and growth. His leadership in developing cutting-edge therapies and sustainable technologies continues to inspire progress in science and industry, making a lasting impact on global health and well-being.